{"id":2520,"date":"2025-11-17T14:39:26","date_gmt":"2025-11-17T14:39:26","guid":{"rendered":"https:\/\/www.finznest.com\/blog\/stocks-making-big-moves-premarket-alphabet-zymeworks-and-more\/"},"modified":"2025-11-17T14:39:26","modified_gmt":"2025-11-17T14:39:26","slug":"stocks-making-big-moves-premarket-alphabet-zymeworks-and-more","status":"publish","type":"post","link":"https:\/\/www.finznest.com\/blog\/stocks-making-big-moves-premarket-alphabet-zymeworks-and-more\/","title":{"rendered":"Stocks making big moves premarket: Alphabet, Zymeworks and more"},"content":{"rendered":"<div>\n<div data-test=\"articleBody-2\" data-analytics=\"RegularArticle-articleBody-5-2\">\n<p><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"xyz-data\">Check out the companies making headlines in premarket trading. Alphabet \u2014 The YouTube and Google owner rose more than 4% after Warren Buffett&#8217;s Berkshire Hathaway revealed it took a more than $4 billion stake in Alphabet in the third quarter. Zymeworks and Jazz Pharmaceuticals \u2014 Drugmakers Zymeworks and Jazz Pharmaceuticals reported Phase 3 trial results of their cancer drug Ziihera. Zymeworks shares surged about 35%, while Jazz rose nearly 21%. Lithium stocks \u2014 Citing a local Chinese news source, Bloomberg reported Ganfeng Lithium Group Company chairman Li Liangbin forecast Sunday that lithium demand will grow 30% in 2026. Albemarle, the largest U.S. producer, climbed 4%; Sigma Lithium popped 26%; and Lithium Argentina and Lithium Americas rose about 8% and 3%, respectively. Quantum Computing \u2014 Shares jumped 21% after the quantum computing provider issued a strategic roadmap\u00a0toward scalable quantum and photonic manufacturing. Clearwater Analytics Holdings \u2014 Speculation that Clearwater is weighing a deal to go private drove the stock 10% higher. Bloomberg reported late Friday Friday that Warbug Pincus and Permira are in talks to buy the investment and accounting software maker. Alibaba \u2014 E-commerce giant Alibaba unveiled Qwen App, its revamped Chat GPT-like artificial intelligence application, in China, pushing up its shares 2.5%. Gap \u2014 The apparel retailer added nearly 3% on the back of an upgrade at Barclays to overweight from equal weight. The bank said Gap is executing a disciplined turnaround and should see a durable brand recovery. Apple \u2014 Investors reacted to a Friday report in the Financial Times that Apple is ramping up preparations to identify and name a successor to CEO Tim Cook. Apple fell 1%. Xpeng \u2014 U.S.-listed shares lost nearly 4% after the Chinese electric car maker posted mixed third-quarter results, with its adjusted loss coming in narrower than analysts polled by FactSet had expected, while revenue roughly matched estimates. Fourth-quarter revenue guidance fell short of the consensus estimate. Aramark \u2014 The food services provider dropped 7% after fiscal fourth-quarter adjusted earnings of 57 cents trailed the 64 cents that analysts polled by FactSet had expected. Aramark&#8217;s $5.05 billion revenue also fell short of the $5.16 billion consensus. Aramark guidance for the fiscal year ending Sept. 2026 of adjusted earnings per share of $2.18 per share to $2.28 compared with the $2.27 analysts were expecting. \u2014 CNBC&#8217;s Michelle Fox-Theobald, Fred Imbert, Sean Conlon, Alex Harring and Lisa Han contributed reporting<\/span><\/span><\/span><span class=\"HighlightShare-hidden\" style=\"top:0;left:0\"\/><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Check out the companies making headlines in premarket trading. Alphabet \u2014 The YouTube and Google owner rose more than 4% after Warren Buffett&#8217;s Berkshire Hathaway revealed it took a more than $4 billion stake in Alphabet in the third quarter. Zymeworks and Jazz Pharmaceuticals \u2014 Drugmakers Zymeworks and Jazz Pharmaceuticals reported Phase 3 trial results [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2521,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[338,365,371,373,559,238,1673],"class_list":["post-2520","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-alphabet","tag-big","tag-making","tag-moves","tag-premarket","tag-stocks","tag-zymeworks"],"_links":{"self":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts\/2520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/comments?post=2520"}],"version-history":[{"count":0,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts\/2520\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/media\/2521"}],"wp:attachment":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/media?parent=2520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/categories?post=2520"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/tags?post=2520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}